First Time Loading...

Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 564 JPY -3% Market Closed
Updated: May 19, 2024

Gross Margin
Kobayashi Pharmaceutical Co Ltd

55.5%
Current
56%
Average
31.5%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
55.5%
=
Gross Profit
98B
/
Revenue
176.5B

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
413.6B JPY
56%
FR
L'Oreal SA
PAR:OR
239.3B EUR
74%
UK
Unilever PLC
LSE:ULVR
107.9B GBP
42%
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR
52%
US
Estee Lauder Companies Inc
NYSE:EL
48.3B USD
71%
UK
HALEON PLC
LSE:HLN
30.4B GBP
62%
DE
Beiersdorf AG
XETRA:BEI
32.8B EUR
57%
JP
Kao Corp
TSE:4452
3.2T JPY
38%
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR
55%
JP
Shiseido Co Ltd
TSE:4911
2T JPY
74%
IN
Dabur India Ltd
NSE:DABUR
949.5B INR
48%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Country JP
Market Cap 413.6B JPY
Gross Margin
56%
L'Oreal SA
PAR:OR
Country FR
Market Cap 239.3B EUR
Gross Margin
74%
Unilever PLC
LSE:ULVR
Country UK
Market Cap 107.9B GBP
Gross Margin
42%
Hindustan Unilever Ltd
NSE:HINDUNILVR
Country IN
Market Cap 5.5T INR
Gross Margin
52%
Estee Lauder Companies Inc
NYSE:EL
Country US
Market Cap 48.3B USD
Gross Margin
71%
HALEON PLC
LSE:HLN
Country UK
Market Cap 30.4B GBP
Gross Margin
62%
Beiersdorf AG
XETRA:BEI
Country DE
Market Cap 32.8B EUR
Gross Margin
57%
Kao Corp
TSE:4452
Country JP
Market Cap 3.2T JPY
Gross Margin
38%
Godrej Consumer Products Ltd
NSE:GODREJCP
Country IN
Market Cap 1.3T INR
Gross Margin
55%
Shiseido Co Ltd
TSE:4911
Country JP
Market Cap 2T JPY
Gross Margin
74%
Dabur India Ltd
NSE:DABUR
Country IN
Market Cap 949.5B INR
Gross Margin
48%

Profitability Report

View the profitability report to see the full profitability analysis for Kobayashi Pharmaceutical Co Ltd.

Full Profitability Report

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
55.5%
=
Gross Profit
98B
/
Revenue
176.5B
What is the Gross Margin of Kobayashi Pharmaceutical Co Ltd?

Based on Kobayashi Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 55.5%.

ALPHA SPREAD
Join more than 138,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.